Chun-kai Huang

No. 7, Chung Shan S. Rd, 
TPQ, TW 
No. 7, Chung Shan S. Rd, 
TPQ, TW 

Overview

Chun-kai Huang practices practicing medicine in Taiwan.

Their clinical expertise encompasses Fabry Disease, Pneumonia, Pompe Disease, and Nontuberculous Mycobacterial Lung Disease.

They are actively involved in clinical research, co-authoring 65 peer reviewed articles and participating in 1 clinical trial.

Locations

No. 7, Chung Shan S. Rd, TPQ, Taiwan
Other Locations
No. 7, Chung Shan South Road, TPQ 10002, Taiwan
128, Sec. 2, Academia Rd, TPQ 11529, Taiwan
No. 7, Zhongshan South Road, TPQ 10002, Taiwan
No. 1, Sec. 4, Roosevelt Road, TPQ 10617, Taiwan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Prospective, Therapeutic Drug Monitoring Study of Reduced-Dose Efavirenz (400 mg) Plus Tenofovir Disoproxil Fumarate (TDF) and Lamivudine in a Fixed-Dose Combination Tablet (Combo) for Patients Receiving Co-Formulated TDF, Emtricitabine and Efavirenz (Atripla) With Viral Suppression in Taiwan
Prospective, Therapeutic Drug Monitoring Study of Reduced-Dose Efavirenz (400 mg) Plus Tenofovir Disoproxil Fumarate (TDF) and Lamivudine in a Fixed-Dose Combination Tablet (Combo) for Patients Receiving Co-Formulated TDF, Emtricitabine and Efavirenz (Atripla) With Viral Suppression in Taiwan
Enrollment Status: Completed
Publish Date: February 07, 2020
Intervention Type: Drug
Study Phase: Phase 3

65 Total Publications

Unveiling previously undescribed circadian clock regulators and action mechanisms via TurboID-based profiling of the LWD1 interactome in Arabidopsis thaliana.
Unveiling previously undescribed circadian clock regulators and action mechanisms via TurboID-based profiling of the LWD1 interactome in Arabidopsis thaliana.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 05, 2026

Frequently Asked Questions about Chun-kai Huang

Is Chun-kai Huang a top-rated expert for Fabry Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Chun-kai Huang is classified as an Experienced expert for Fabry Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Chun-kai Huang participate in research or clinical trials?

Yes. Chun-kai Huang has published 65 articles and abstracts on conditions like Fabry Disease. You can view a list of Chun-kai Huang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Huang's expertise for a condition
ConditionClose
        View All 13 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile